Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

An Evaluation of the Neuromuscular Junction in Neonates Using the TetraGraph

NCT: NCT07133412 · NOT_YET_RECRUITING

NCT IDNCT07133412
StatusNOT_YET_RECRUITING
Start Date2026-07
Completion2027-12

Brief Summary

The goal of this study is to use electromyography-based train-of-four monitoring (TetraGraph™ Neuromuscular Transmission Monitor) as a means of evaluating differences in neuromuscular transmission between infants ≤ 3 months of age and adolescent and older patients (≥ 12 years of age).

Frequently Asked Questions

What is An Evaluation of the Neuromuscular Junction in Neonates Using the TetraGraph?

An Evaluation of the Neuromuscular Junction in Neonates Using the TetraGraph is a clinical trial registered under NCT07133412. Current status: NOT_YET_RECRUITING.

What is the status of NCT07133412?

The current status of NCT07133412 (An Evaluation of the Neuromuscular Junction in Neonates Using the TetraGraph) is: NOT_YET_RECRUITING.

When did An Evaluation of the Neuromuscular Junction in Neonates Using the TetraGraph start?

An Evaluation of the Neuromuscular Junction in Neonates Using the TetraGraph started on 2026-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑